Table 1.
3 h p.i. | 9 h p.i. | |||
MOCK | SARS-CoV | MOCK | SARS-CoV | |
TLR-1 | p = 0.02 | - | - | - |
TLR-2 | p = 0.003 | p = 0.003 | p = 0.003 | p = 0.003 |
TLR-3 | - | - | - | - |
TLR-4 | - | p = 0.03 | - | - |
TLR-5 | p = 0.004 | - | p = 0.04 | - |
TLR-6 | - | - | - | - |
TLR-7 | p = 0.04 | - | - | - |
TLR-8 | - | - | - | - |
TLR-9 | - | - | - | - |
CCR-1 | - | p = 0.02 | - | p = 0.005 |
CCR-3 | - | - | - | - |
CCR-5 | - | - | - | p = 0.02 |
CCR-7 | p = 0.02 | p = 0.01 | - | p = 0.03 |
FasL | - | - | - | - |
TRAIL | - | p = 0.005 | - | p = 0.01 |
**Adult DCs (n = 7)
CB DCs (n = 5)
TLR, toll-like receptor; CCR, chemokine receptor; FasL, Fas ligand; TRAIL, Tumor necrosis factor (TNF)-related apoptosis-inducing ligand